Important Progress Made in Breast Cancer Single-Cell Atlas Research
Breast cancer is one of the most common malignant tumors in women and a leading cause of cancer-rela...
EU Approves Kinase Inhibitor Iclusig for First-Line Treatment of Ph+ ALL
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has reco...
HemostOD Secures CHF 2 Million in Innosuisse Funding to Advance Donor-Free Platelet Preclinical Development
Wedoany.com Report on Feb 10th, HemostOD announced that it has secured CHF 2 million (approximately USD 2.5 mil...
Detailed Explanation of PrEP Administration Methods, Long-Acting Injections Offer a New Choice for HIV Prevention
For individuals seeking PrEP (pre-exposure prophylaxis), an HIV test is first required. If the test ...
Hereditary Hemochromatosis: Iron Overload Disorder and Its Diagnosis & Treatment
Hemochromatosis, an iron overload disorder, is a hereditary condition often missed due to its subtle...
Study on Hormonal Contraceptives and Cardiovascular Risk Reveals Differences in Impact of Stress Disorders
A recent study published in the journal JAMA Network Open explored the impact of hormonal contracept...
DSM Diagnostic Manual Set for Update, Psychiatry Guidelines to Undergo Transformation
The American Psychiatric Association recently announced the development strategy for the next genera...
Overactive Immune T Cells May Worsen Heart Failure, Targeted Therapy Research Offers New Direction
Approximately 64 million people worldwide suffer from heart failure. Due to a lack of effective trea...
Chlorpromazine Supply Restored, French Largactil 100 mg Tablets Back on the Market
The French National Agency for the Safety of Medicines and Health Products (ANSM) announced...
OpenAI Plans Multi-Modal Support for Pharmaceutical Companies in Drug R&D, Exploring New Collaborations in the Medical Field
On February 4th, it was reported that OpenAI CEO Sam Altman revealed that the company is planning to...